Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01756573 · ClinicalTrials.gov registry record · NA
Dexamethasone and Block Duration in Upper Extremity
A NA study, sponsored by University of Chicago.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT01756573: Clinical Trial NA study, sponsored by University of Chicago.
NCT01756573 is a NA study that was terminated before completion, run by University of Chicago. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01756573, a NA study, was terminated before completion, sponsored by University of Chicago.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
Effect of dexamethasone on prolonging upper extremity block is well known. But it not known if the effect comes from its local effect on the nerves or from its general analgesic effect. In this study we will compare the systemic effect to its local effect to find out if there is a difference or not.
Interventions
- DRUG Bupivacaine
- DRUG Dexamthsone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2013-01 |
| Est. Completion | 2015-01 |
| Phase | NA |
Why NCT01756573 stopped before completion
NCT01756573 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Bupivacaine is the first listed.
NCT01756573 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01756573 about?
NCT01756573 is a clinical study titled "Dexamethasone and Block Duration in Upper Extremity". Effect of dexamethasone on prolonging upper extremity block is well known. But it not known if the effect comes from its local effect on the nerves or from its general analgesic effect. In this study we will compare the systemic effect to its local effect to find out if there is a difference or not.
What is the current status of trial NCT01756573?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2013-01. Estimated completion is 2015-01.
What interventions are being tested in trial NCT01756573?
The interventions under investigation include: Bupivacaine (DRUG), Dexamthsone (DRUG).
Who is sponsoring clinical trial NCT01756573?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01756573's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia